Cart
sales@molnova.com
CBP-IN-1
CAS No. 2222941-37-7
CBP-IN-1( —— )
Catalog No. M22843 CAS No. 2222941-37-7
CBP-IN-1 is a potent inhibitor of p300/CBP bromodomain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 84 | In Stock |
|
| 5MG | 140 | In Stock |
|
| 10MG | 250 | In Stock |
|
| 25MG | 528 | In Stock |
|
| 50MG | 755 | In Stock |
|
| 100MG | 1017 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCBP-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCBP-IN-1 is a potent inhibitor of p300/CBP bromodomain.
-
DescriptionCBP-IN-1 is a potent inhibitor of p300/CBP bromodomain.
-
In Vitro——
-
In VivoAnimal Model:Noncastrated male athymic nude mice Dosage:10-30 mg/kg Administration:Oral gavage; at 10 or 20 mg/kg daily (QD) or at 30 mg/kg every other day (QOD) for 28 days Result:Affected tumor growth at 10 mg/kg daily, 20 mg/kg daily, and 30 mg/kg every other day.
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
Recptorp300/CBP
-
Research Areacancer
-
IndicationHaematological Malignancy|Acute Myeloid Leukemia|Non Hodgkin Lymphoma|Multiple Myeloma
Chemical Information
-
CAS Number2222941-37-7
-
Formula Weight534.6
-
Molecular FormulaC30H32F2N4O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (187.06 mM; Need ultrasonic)
-
SMILESO=C1N(C2=CC=C(F)C(F)=C2)[C@H](C3=NC4=CC(C5=C(C)ON=C5C)=CC=C4N3[C@H]6CC[C@H](OC)CC6)CCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Neil Anthony Pegg, et al. Pharmaceutical compounds. WO2018073586A1.
molnova catalog
related products
-
SR-0813
SR-0813 is a potent and selective inhibitor of the YEATS domain in ENL/AF9, with an IC50 of 25 nM and EC50 of 205 nM for the ENL YEATS domain, and an IC50 of 311 nM and EC50 of 76 nM (CETSA) for the AF9 YEATS domain.
-
BRD4 Inhibitor-20
BRD4 Inhibitor-20 is a potent bromodomain protein 4 (BRD4) inhibitor with oral activity, demonstrating antiproliferative effects in cancer cell lines and used in studies of various cancers, including colon cancer.
-
OXF BD 02
OXF BD 02 is a potent and selective BRD4(1) inhibitor (IC50: 382 nM) with anticancer and anti-inflammatory activity.
